Effects of Different Administration Cycles of Rhubarb on Fecal Metabolism in Healthy Rats Based on Metabolomics

ABSTRACT

Background: Rhubarb is a common cold-property drug that is commonly used as an effective laxative. It was first recorded in Shen Nong’s Herbal Classic. Purpose: The LC-MS/MS metabolomics technology was used in this study to investigate the possible mechanism by which Rhubarb, a common cold property in Traditional Chinese Medicine, acts on healthy rats during different administration cycles. Discussing the effect of bitter-cold Traditional Chinese Medicine on the intestinal tract, not only guides clinical medicine better but also provides a new way to evaluate the efficacy of bitter-cold Chinese medicine objectively. Materials and Methods: Six groups of rats (n = 6) were randomly divided into the following: the control group was fed a basal diet and given pure water; the Rhubarb group was fed a basal diet and was gavaged with Rhubarb (7.5 g/kg per day). The principal component analysis and the orthogonal partial least squares–discriminant analysis method was used to analyse the endogenous differential metabolites, the metabolite differences between rhubarb and the control group were screened, and the metabolic pathways were analysed by MetaboAnalyst. Results: Compared with the blank control group, 20, 17, and 8 metabolites were identified in the feces of the Rhubarb group on the 7th, 14th, and 21st days, respectively, which involved linoleic acid metabolism, purine metabolism, tryptophan metabolism, and arachidonic acid metabolism. Conclusion: Rhubarb’s pharmacological effects on gastrointestinal regulation, and antibacterial, and anti-inflammatory properties are closely related to its bitter and cold properties and may be generated through porphyrin, purine, tryptophan, and arachidonic acid metabolism pathways.

KEYWORDS

• Rhubarb
• metabolomics
• endogenous metabolites
• medicinal properties of Chinese herbs
• LC-MS/MS

Showing references and in-text citations exactly as published.

• DOI10.1177/09731296241245179Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Mag..

• Article · VOLUME 20, ISSUE 4Fraxinus excelsior L. for Prevention of Capecitabine-induced Enterocolitis in Rat: An Integrated Biochemical, Molecular, and Histopathological StudyLi Li, HaiYan Tan, TianLu Su · pp. 1086–1099Original Research ArticleSame type: Article
• Article · VOLUME 20, ISSUE 4Lijing-Anfei Decoction Attenuates COPD in a Mouse Model: Network Pharmacology Analysis, Molecular Docking, and Experimental ValidationJiajia Zhu, Jie Liu, Wei Jia, Guoqiang Shao, Haizhu Xu · pp. 1100–1113Original Research ArticleSame type: Article
• Article · VOLUME 20, ISSUE 4Anticancer Effects of Vaccinium arctostaphylos L. through HOTAIR/miR-124/Notch1 Axis of Hepatocellular Carcinoma in Rat: A Biochemical, Molecular, Immunohistochemical, and Histopathological ApproachesChengchen Zhou, Xiaoling Qin, Jingyi Wang, Yongchang Liu · pp. 1114–1127Original Research ArticleSame type: Article
• Article · VOLUME 20, ISSUE 4Eriocitrin in the Treatment of Diabetic Nephropathy: Amelioration Against Oxidative Burst and Inflammation ApproachHui Deng, Yarong Li, Shulan Han, Min Lan, Liqin Cui, Tahani Awad Alahmadi, Sulaiman Ali Alharbi, Zhong Li · pp. 1128–1140Original Research ArticleSame type: Article